Immunogenicity and Safety of ADACEL™ (TdcP Vaccine) as Fifth Dose in Children 6-8 Years of Age.
Phase of Trial: Phase III
Latest Information Update: 04 Apr 2014
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics
- Sponsors Sanofi
- 16 Jun 2009 Actual number of patients (115), official title added as reported by ClinicalTrials.gov.
- 09 Dec 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Sep 2006 Status change